Form 4: RGA Executive Exercises RSUs, Sells Shares for Tax
Insider Transaction Report
REINSURANCE GROUP OF AMERICA INC's EVP, Chief HR Officer, Raymond Kleeman, exercised restricted share units and sold a portion of the resulting common stock to cover tax liabilities.
Summary
- Raymond Kleeman, EVP, Chief HR Officer of REINSURANCE GROUP OF AMERICA INC (RGA), reported multiple transactions on January 15, 2026.
- Exercised 308 Restricted Share Units (RSUs) granted March 6, 2025, which vested in 33 and 1/3% increments over three years and fully vest on December 31, 2027, converting to 308 shares of common stock.
- Exercised 310 Restricted Share Units (RSUs) granted March 15, 2024, which vested in 33 and 1/3% increments over three years and fully vest on December 31, 2026, converting to 310 shares of common stock.
- Exercised 976 Restricted Share Units (RSUs) granted March 15, 2023, which fully vested on December 31, 2025, converting to 976 shares of common stock.
- A total of 1,594 shares were acquired through these RSU exercises.
- Subsequently disposed of 106 shares, 91 shares, and 305 shares (totaling 502 shares) at a price of $196.73 per share to cover tax obligations.
- Following these transactions, Raymond Kleeman beneficially owns 7,697 shares of RGA common stock directly.
Sentiment
Score: 6
Explanation: The filing reports a routine insider transaction where an executive exercised vested equity awards and sold shares to cover tax liabilities. This is a neutral event, reflecting the normal course of executive compensation and value realization, rather than a significant positive or negative indicator for the company's operational performance or strategic direction.
Positives
- Executive Raymond Kleeman realized value from previously granted Restricted Share Units, indicating successful vesting of long-term incentives.
- The exercise of RSUs demonstrates the executive's continued participation in the company's equity compensation plan.
Negatives
- A portion of the acquired shares (502 shares) was sold to cover tax liabilities, resulting in a reduction of direct beneficial ownership from the acquired amount.
Risks
- No specific new risks are introduced by this routine insider transaction. General market risks associated with holding RGA common stock remain.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance. It reports past insider transactions.
Industry Context
This Form 4 filing details a routine insider transaction related to executive compensation and does not provide information relevant to broader industry trends or competitor analysis. Such transactions are common across all industries for executives receiving equity compensation.
Comparison to Industry Standards
- This filing reports a standard executive compensation event (RSU vesting and tax-related share sales).
- These types of transactions are common practice for executives in publicly traded companies across the financial and insurance sectors, including peers like MetLife, Prudential Financial, and Aflac, where equity-based incentives are a significant component of executive pay.
- The specific details of RSU grants and vesting schedules are typical for long-term incentive plans designed to align executive interests with shareholder value over multi-year periods.
Stakeholder Impact
- Shareholders: The transaction is a routine part of executive compensation and does not indicate a change in company fundamentals. The sale of shares for tax purposes is a common occurrence and typically has minimal impact on the overall share price or shareholder value.
- Employees: No direct impact on employees beyond the reporting person.
- Management: The reporting person, Raymond Kleeman, continues to hold a significant number of shares, maintaining alignment with shareholder interests.
Next Steps
- The remaining unvested portions of the Restricted Share Units granted on March 6, 2025, will continue to vest in 33 and 1/3% increments over three years, fully vesting on December 31, 2027.
- The remaining unvested portions of the Restricted Share Units granted on March 15, 2024, will continue to vest in 33 and 1/3% increments over three years, fully vesting on December 31, 2026.
Key Dates
| Date | Description |
|---|---|
| 03/15/2023 | Grant date for 976 Restricted Share Units. |
| 03/15/2024 | Grant date for 310 Restricted Share Units. |
| 03/06/2025 | Grant date for 308 Restricted Share Units. |
| 12/31/2025 | Full vesting date for 976 Restricted Share Units granted March 15, 2023. |
| 01/15/2026 | Transaction date for RSU exercises and share dispositions. |
| 01/20/2026 | Signature date of the reporting person. |
| 12/31/2026 | Full vesting date for 310 Restricted Share Units granted March 15, 2024. |
| 12/31/2027 | Full vesting date for 308 Restricted Share Units granted March 6, 2025. |
Recommendation
holdThis Form 4 filing details a routine insider transaction involving the exercise of vested Restricted Share Units and subsequent sale of shares to cover tax obligations. Such transactions are common and often pre-planned, providing no new material information regarding the company's operational performance, strategic direction, or financial health. Therefore, it does not warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate RGA based on its fundamental business performance, financial reports, and broader market conditions.
Keywords
REINSURANCE GROUP OF AMERICA INC, RGA, Form 4, insider transaction, executive compensation, Restricted Share Units, RSU, stock sale, tax withholding, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.